United States · Who invested in Magnolia Neuroscience?
Magnolia Neuroscience's investors include Eli Lilly, Alexandria Real Estate Equities, Pfizer, AbbVie and Arch, and 6 more on record.
United States · Series A startup
Who invested in Magnolia Neuroscience
One round we have observed, with the 11 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$31Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $31MAug 2018
- Investors
- 11
The rounds
- Aug 2018Series A$31M
Eli Lilly
Alexandria Real Estate Equities
Pfizer
AbbVie
Arch
WuXi AppTec- JJDC
Partnership Fund for New York City- 180 Degree
- Innovate NY Fund
- Watson Fund
Reported by FinSMEs
Everyone who backed them
JJDCInvestment firm1round
180 Degreeno record of our own yet1round
Innovate NY Fundno record of our own yet1round
Watson Fundno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Magnolia Neuroscience
How much has Magnolia Neuroscience raised?
Magnolia Neuroscience has raised $31M across 1 round since 2018.
When did Magnolia Neuroscience last raise?
Magnolia Neuroscience's most recent round was a Series A of $31M in Aug 2018.
What was Magnolia Neuroscience's biggest round?
Its most recent round, $31M in Aug 2018, is also its largest on record.
Who backed Magnolia Neuroscience first?
Magnolia Neuroscience's first round on record, in Aug 2018, was backed by Eli Lilly, Alexandria Real Estate Equities and Pfizer and 8 others.
What stage is Magnolia Neuroscience at?
Magnolia Neuroscience's latest named round is a Series A, in Aug 2018.
Where is Magnolia Neuroscience based?
Magnolia Neuroscience is based in the United States.
Companies like Magnolia Neuroscience
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.